Cited 0 times in
The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, BR | - |
dc.contributor.author | Lee, YA | - |
dc.contributor.author | Won, SJ | - |
dc.contributor.author | Noh, JH | - |
dc.contributor.author | Chang, SY | - |
dc.contributor.author | Chung, JM | - |
dc.contributor.author | Choi, JS | - |
dc.contributor.author | Joo, CK | - |
dc.contributor.author | Yoon, SH | - |
dc.contributor.author | Gwag, BJ | - |
dc.date.accessioned | 2011-07-13T02:07:20Z | - |
dc.date.available | 2011-07-13T02:07:20Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | 0022-3565 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/3297 | - |
dc.description.abstract | Sulfasalazine is widely used to treat inflammatory diseases. Besides anti-inflammatory actions such as blockade of nuclear factor-kappaB and cyclooxygenases, we found that 30 to 1000 micro M sulfasalazine dose dependently blocked N-methyl-D-aspartate receptor-mediated excitotoxicity without intervening kainate or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid neurotoxicity. The neuroprotective effects of sulfasalazine were attributable to prevention of Ca(2+) influx and accumulation through N-methyl-D-aspartate receptors as a low-affinity antagonist. The systemic administration of sulfasalazine reduced neuronal death following transient cerebral and retinal ischemia in adult rat. The present findings suggest that the neuroprotective action of sulfasalazine can be therapeutically applied to halt devastating neuronal death following hypoxic ischemia, trauma, and neurodegenerative diseases. | - |
dc.language.iso | en | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antioxidants | - |
dc.subject.MESH | Calcium | - |
dc.subject.MESH | Cells, Cultured | - |
dc.subject.MESH | Cerebral Cortex | - |
dc.subject.MESH | Cyclooxygenase 2 | - |
dc.subject.MESH | Disease Models, Animal | - |
dc.subject.MESH | Ischemia | - |
dc.subject.MESH | Isoenzymes | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred ICR | - |
dc.subject.MESH | N-Methylaspartate | - |
dc.subject.MESH | NF-kappa B | - |
dc.subject.MESH | Neuroprotective Agents | - |
dc.subject.MESH | Prostaglandin-Endoperoxide Synthases | - |
dc.subject.MESH | Rats | - |
dc.subject.MESH | Rats, Sprague-Dawley | - |
dc.subject.MESH | Receptors, N-Methyl-D-Aspartate | - |
dc.subject.MESH | Retinal Diseases | - |
dc.subject.MESH | Sulfasalazine | - |
dc.title | The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. | - |
dc.type | Article | - |
dc.identifier.pmid | 12649352 | - |
dc.identifier.url | http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=12649352 | - |
dc.contributor.affiliatedAuthor | 곽, 병주 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1124/jpet.102.042606 | - |
dc.citation.title | The Journal of pharmacology and experimental therapeutics | - |
dc.citation.volume | 305 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2003 | - |
dc.citation.startPage | 48 | - |
dc.citation.endPage | 56 | - |
dc.identifier.bibliographicCitation | The Journal of pharmacology and experimental therapeutics, 305(1). : 48-56, 2003 | - |
dc.identifier.eissn | 1521-0103 | - |
dc.relation.journalid | J000223565 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.